We are pleased to announce details of a new OBN Digital BioTuesday we are running in collaboration with Bruntwood SciTech, which will address the potential that RNA technologies have to disrupt the product developmentand drug discovery landscape as we know it.
Researchers have been studying and working with RNA molecules for decades. However, on the example of the mRNA vaccines, the pandemic has accelerated this transformative technology and following unprecedented industry collaborations, we have now seen the world’s first mRNA vaccine being rolled out to the wider population - this session will look at the future potential for this exciting technology, and we will hear from some of the most exciting R&D companies using RNA technology in their product development - please see below for more details.
This session will be run in a live format using Zoom Webinar, with registration open for both OBN Members and Non-Members.
A live Q&A will follow the company showcase presentations and audience members will be encouraged to engage with speakers by sending their questions in during the event.
Virtual networking will take place using Remo after the Zoom Webinar session ends. The platform facilitates fluid, engaging and authentic interaction between attendees, on virtual tables in a conference room. The platform allows you to connect with one another in real-time, without the need to book, by simply clicking on the virtual table of your choice. When you have selected a table, a live video conversation will be launched with the other table participants, allowing you to chat informally, share news and plan follow-up communications accordingly.
